ARTICLE | Clinical News
Mylotarg gemtuzumab zogamicin regulatory update
March 20, 2000 8:00 AM UTC
The FDA's Oncologic Drugs Advisory Committee voted 11-2 to recommend accelerated approval of the partners' NDA for Mylotarg, a humanized antibody against CD33 linked to the calicheamicin cytotoxin, t...